Project no.: HIV-NAT 110
A multicenter randomized study to compare the efficacy and safety of lower dose atazanavir/ritonavir (ATV/r 200/100 mg OD) versus standard dose (ATV/r 300/100 mg OD) in combination with 2NRTIs in well virology suppressed HIV-infected adults
Presentation: Bencharat T, Chavalun R, Mark B, Peeraporn K, Chalandakorn R, Alli H, Wipada C, Anchalee A, Kiat R, Torsak B on behalf of LASA study team. Acceptability of web-based electronic data capture in a multicentre randomized trial in Thailand. [Poster #265] presented at Australian HIV/AIDS Conference 2012 24th Annual Conference of the Australian Society for HIV Medicine, Melbourne, Australia. 17-19 October 2012.
